Journal article
Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis
B Panizzutti, D Skvarc, S Lin, S Croce, A Meehan, CC Bortolasci, W Marx, AJ Walker, K Hasebe, BE Kavanagh, MJ Morris, M Mohebbi, A Turner, L Gray, L Berk, K Walder, M Berk, OM Dean
International Journal of Molecular Sciences | Published : 2023
DOI: 10.3390/ijms24065250
Abstract
Minocycline has anti-inflammatory, antioxidant, and anti-apoptotic properties that explain the renewed interest in its use as an adjunctive treatment for psychiatric and neurological conditions. Following the completion of several new clinical trials using minocycline, we proposed an up-to-date systematic review and meta-analysis of the data available. The PICO (patient/population, intervention, comparison and outcomes) framework was used to search 5 databases aiming to identify randomized controlled trials that used minocycline as an adjunctive treatment for psychiatric and neurological conditions. Search results, data extraction, and risk of bias were performed by two independent authors f..
View full abstractRelated Projects (1)
Grants
Awarded by Brain and Behavior Research Foundation
Funding Acknowledgements
A.J.W. gratefully acknowledges support from a Trisno Family Fellowship funded in part by an NHMRC CRE (1153607). M.B. is supported by an NHMRC Senior Principal Research Fellowship and Leadership 3 Investigator grant (1156072 and 2017131). W.M. is currently funded by an NHMRC Investigator Grant (#2008971) and a Multiple Sclerosis Research Australia early-career fellowship.